Published results, measured by counting hair
The number of anagen* hair increased by
112% in LH23 group - from 26,6 to 56,3
29% in Placebo group - from 28,2 to 36,4
* Anagen hair consist of hair in growth phase
Anagen/Telogen** ratio increased by
164% in LH23 group
50% placebo
p<0.001
** Telogen hair consist of hair in falling phase
Efficacy and Safety of a Topical Botanical in Female Androgenetic Alopecia: A Randomized, Single-Blinded, Vehicle-Controlled Study.
A Possible New Treatment of Female Androgenetic Alopecia. Katoulis et Al. Skin Appendage Disord 2018;4:160–165